Q'Apel Medical
Fremont, US · Delaware corporation
Q'Apel Medical designs purpose-built devices for neurovascular and stroke care, developing tools focused on catheter access and navigation through complex vascular pathways. It develops these solutions in collaboration with neurovascular clinicians to address unmet clinical needs during stroke interventions.
Founders & leadership
RK
R. King NelsonNamed on SEC filing
CM
Christopher MartinNamed on SEC filing
JA
J. Avi RoopNamed on SEC filing
SH
Scot HuennekensNamed on SEC filing
Board
CM
Carter McNabbBoard director
Reported raises · per SEC filings
Form D private placements$68.9M disclosed across 3 rounds · 2021–2024
▶$17.1MraisedMay 2024 · 6 investors · Other Health CareRule 506(b)
▶$17.1MraisedMay 2024 · 6 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- R. King NelsonExecutive Officer, Director
- Scott HuennekensDirector
- Carter McNabbDirector
- Lennox KetnerDirector
- Christopher MartinDirector
- Offering amount
- $42.1M
- Amount sold
- $17.1M
- First sale
- Apr 2024
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$29.9MraisedMay 2022 · 7 investors · Other Health CareRule 506(b)
▶$29.9MraisedMay 2022 · 7 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Scot HuennekensDirector
- J. Avi RoopDirector
- Carter McNabbDirector
- R. King NelsonExecutive Officer, Director
- Christopher MartinDirector
- Offering amount
- $33M
- Amount sold
- $29.9M
- First sale
- Mar 2022
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$21.9MraisedFeb 2021 · 6 investors · Other Health CareRule 506(b)
▶$21.9MraisedFeb 2021 · 6 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- R. King NelsonExecutive Officer, Director
- Christopher MartinDirector
- J. Avi RoopDirector
- Carter McNabbDirector
- Scot HuennekensDirector
- Offering amount
- $22M
- Amount sold
- $21.9M
- First sale
- Feb 2021
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Competitors · 1
by search overlapCompanies competing with Q'Apel Medical for the same Google search keywords, organic and paid, via search-intersection analysis.
Frequently asked questions
- What does Q'Apel Medical do?
- Q'Apel Medical designs purpose-built devices for neurovascular and stroke care, developing tools focused on catheter access and navigation through complex vascular pathways. It develops these solutions in collaboration with neurovascular clinicians to address unmet clinical needs during stroke interventions.
- How much funding has Q'Apel Medical raised?
- Q'Apel Medical has disclosed $68.9M raised across 3 rounds.
- Where is Q'Apel Medical headquartered?
- Q'Apel Medical is headquartered in Fremont, US.
